Patents by Inventor Howell FOSTER

Howell FOSTER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination Therapy for Male Sexual Dysfunction
    Publication number: 20220008415
    Abstract: Pharmaceutical formulations containing a serotonin reuptake inhibitor and a phosphodiesterase 5 inhibitor are provided for the treatment of premature ejaculation and the increase in intravaginal ejaculatory latency time. Specific formulations contain tadalafil (1-30 mg per dose) and escitalopram (1-30 mg) in daily dose and on-demand formulations.
    Type: Application
    Filed: September 24, 2021
    Publication date: January 13, 2022
    Inventor: Howell FOSTER
  • Combination Therapy for Male Sexual Dysfunction
    Publication number: 20190328733
    Abstract: Pharmaceutical formulations containing a serotonin reuptake inhibitor and a phosphodiesterase 5 inhibitor are provided for the treatment of premature ejaculation and the increase in intravaginal ejaculatory latency time. Specific formulations contain tadalafil (1-30 mg per dose) and escitalopram (1-30 mg) in daily dose and on-demand formulations.
    Type: Application
    Filed: September 8, 2018
    Publication date: October 31, 2019
    Inventor: Howell FOSTER
  • COMBINATION THERAPY FOR MALE SEXUAL DYSFUNCTION
    Publication number: 20170326139
    Abstract: Pharmaceutical formulations containing a serotonin reuptake inhibitor and a smooth muscle relaxant are provided for the treatment of premature ejaculation and the increase in intravaginal ejaculatory latency time. Specific formulations contain tadalafil (1-30 mg per dose) or tamsulosin (0.05-2 mg) and escitalopram (1-30 mg) in daily dose and on-demand formulations.
    Type: Application
    Filed: May 16, 2017
    Publication date: November 16, 2017
    Inventor: Howell FOSTER